Auction date                  July 9, 2020                            
Settlement dateJuly 13, 2020
Maturity dateOctober 5, 2020
Term84 days
Offered volumeUSD 10 billion
Marginal interest raten/a
Per cent of allotment at marginal interest raten/a
Total bid amountUSD 0 billion
AllotmentUSD 0 billion

About GlobeNewswire

One Liberty Plaza - 165 Broadway
NY 10006 New York

GlobeNewswire is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Subscribe to releases from GlobeNewswire

Subscribe to all the latest releases from GlobeNewswire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from GlobeNewswire

Olainfarm Group maintains its profit forecast, a short term decline in 9 month sales results30.11.2020 15:59:00 CETPress release

In 2020, the Olainfarm Group continued its ongoing activity in major sales markets. The highest sales in nine months in 2020 was in Latvia, reaching 28 738 thousand EUR, which is 232 thousand EUR or 1% higher than the same period year ago. Latvia sales represent 32% in Group revenues. Sales in Russia for the nine months period in 2020 amount to 20 590 thousand EUR which is a decrease from 2019 due to extra one-off shipment at the end of 2019 for consumption in the first quarter 2020 amounting to 6 million EUR. “Covid-19 pandemic and restrictions due to it have brought different challenges our way, but we understand how to tackle them, and are committed to reach our growth plans outlined in the company's 5-year strategy. As a long-term investment, we have established a subsidiary in Russia, which allows us to get insights from the medical community and market research so that our efforts are relevant and current to customer needs. I am happy to announce that the new business model in Ru

Kommuniké från extra bolagsstämma i Active Biotech samt justering av tidigare kommunicerad tidplan avseende nyemissionen30.11.2020 15:30:00 CETPressemelding

Extra bolagsstämma i Active Biotech AB (publ) hölls den 30 november 2020. Stämman beslutade, i enlighet med styrelsens förslag, om nyemission med företrädesrätt för aktieägarna. Genom nyemissionen ges högst 72 618 240 nya aktier ut. Två befintliga aktier berättigar till teckning av en ny aktie. Nyemissionen omfattas av vederlagsfria teckningsåtaganden och emissionsgarantier om cirka 40,0 miljoner kronor. Teckningskursen uppgår till 1,05 kronor per aktie. Avstämningsdag för rätt att delta i nyemissionen är den 4 januari 2021. Teckning av de nya aktierna ska ske under perioden 7 – 21 januari 2021. Ett prospekt avseende nyemissionen kommer att offentliggöras före teckningsperiodens början. Preliminär tidplan Sista dag för handel i Active Biotech-aktien inklusive rätt att delta i emissionen infaller den 29 december 2020, istället för den 30 december 2020 som tidigare har kommunicerats. 30 november 2020Extra bolagsstämma 29 december 2020Sista dag för handel i Active Biotech-aktien inklusive

Report from extraordinary general meeting in Active Biotech and adjustment of previously communicated timetable for the rights issue30.11.2020 15:30:00 CETPress release

An extraordinary general meeting of Active Biotech was held on November 30, 2020. The meeting resolved, in accordance with the board’s proposal, on a new share issue with pre-emptive rights for existing shareholders. Through the rights issue, not more than 72,618,240 new shares are issued. Two existing shares entitle to subscription for one new share. The rights issue is covered by free of charge subscription commitments and issue guarantees of approximately SEK 40.0 million. The subscription price amounts to SEK 1.05 per share. The record date for participation in the rights issue is January 4, 2021. Subscription for the new shares shall be made during the period 7 – 21 January 2021. A prospectus regarding the rights issue will be made public prior to the commencement of the subscription period. Preliminary timetable Last day for trading in the Active Biotech share including the right to participate in the rights issue is December 29, 2020, instead of December 30, 2020 as previously c

ITCL - Annual General Meeting 202030.11.2020 15:18:40 CETPress release

Independent Tankers Corporation Limited (the "Company") advises that the 2020 Annual General Meeting of the Company will be held on December 23, 2020. The record date for voting at the Annual General Meeting is set to December 2, 2020. The notice, agenda and associated material will be distributed prior to the meeting. Hamilton, Bermuda November 30, 2020 This information is subject to the disclosure requirements pursuant to Section 5-12 the Norwegian Securities Trading Act

Bombardier Appoints Bart Demosky Executive Vice President and Chief Financial Officer30.11.2020 14:55:00 CETPress release

MONTREAL, Nov. 30, 2020 (GLOBE NEWSWIRE) -- Bombardier (TSX: BBD.B) announced today the appointment of Bart Demosky as Executive Vice President and Chief Financial Officer, effective immediately. Bart will report to Éric Martel, President and Chief Executive Officer, Bombardier Inc., replacing John Di Bert who will be leaving the Company. “We are very excited to welcome Bart to the Bombardier leadership team,” said Éric Martel. “He is an accomplished leader with broad financial experience and an impressive track record of success at some of Canada’s largest corporations. Bart’s deep knowledge and expertise in all aspects of corporate finance will serve us well as we complete our strategic repositioning to a leaner, more focused company. I’m confident that Bart will provide strong leadership as we manage through the current economic challenges and continue to position Bombardier for the future.” Bart brings over 30 years of experience leading organizational transformations and building